A possible role of reduced CDH16 expression for a subset of follicular thyroidal neoplasms is consistent with the 13.8% adenomas and the 40.3% follicular carcinomas with CDH16 negativity in this study. This evidence concerns the gene CDH16 and thyroid gland follicular carcinoma.